Skip to main content
Log in

The Significance of the Furosemide Test for Predicting Ascites Control by Diuretics in Cirrhotics: A Comparison with Volume Expansion and Octreotide Infusion

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

To verify prospectively the usefulness of the furosemide-induced natriuresis test in predicting ascites control by medical treatment, 15 stable cirrhotics (9 male) with ascites were studied. Sodium excretion was measured after this test and after volume expansion with saline associated with intravenous infusion of octreotide; 6 months later, response to medical treatment was rated as good (N=9) or poor (N=6). Patients with poor ascites control had lower sodium excretion with the furosemide-induced natriuresis test (median, 88 vs 201 mmol; P < 0.01). Poor control was observed in four of four patients with sodium excretion ≤125 mmol, and good control in six of six patients with sodium excretion >175 mmol (P < 0.002). Volume expansion was followed by limited natriuresis (median, 20 mmol), in inverse relationship with plasma active renin concentration (P < 0.001). In conclusion, long-term ascites control is well predicted by the furosemide-induced natriuresis test.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. D’Amico G, Morabito A, Pagliaro L, Marubini E (1986) Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 31:468–475

    Article  PubMed  CAS  Google Scholar 

  2. Bories P, Garcia Compean D, Michel H, Bourel M, Capron JP, Gauthier A, Lafon J, Levy VG, Pascal JP, Quinton A (1986) The treatment of refractory ascites by the LeVeen shunt. A multi-centre controlled trial (57 patients). J Hepatol 3:212–218

    Article  PubMed  CAS  Google Scholar 

  3. Spahr L, Villeneuve JP, Tran HK, Pomier-Layrargues G (2001) Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites. Hepatology 33:28–31

    Article  PubMed  CAS  Google Scholar 

  4. Runyon BA (2004) Management of adult patients with ascites due to cirrhosis. Hepatology 39:841–856

    Article  PubMed  Google Scholar 

  5. Perez-Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, Rivera F, Rodes J (1983) Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology 84:961–968

    PubMed  CAS  Google Scholar 

  6. Wang SS, Lee FY, Wu SL, Hwu CM, Chien CH, Lee SD, Tsai YT, Chao Y, Chen CC, Wang PS (1997) Effects of long-term administration of octreotide on sodium retention and atrial natriuretic peptide in carbon tetrachloride-induced cirrhotic rats. J Hepatol 26:1128–1134

    Article  PubMed  CAS  Google Scholar 

  7. Moller S, Brinch K, Henriksen JH, Becker U (1997) Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol 26:1026–1033

    Article  PubMed  CAS  Google Scholar 

  8. Guevara M, Gines P, Fernandez-Esparrach G, Sort P, Salmeron JM, Jimenez W, Arroyo V, Rodes J (1998) Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 27:35–41

    Article  PubMed  CAS  Google Scholar 

  9. Kubba AK, Dallal H, Haydon GH, Hayes PC, Palmer KR (1999) The effect of octreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man. Am J Gastroenterol 94:1077–1082

    Article  PubMed  CAS  Google Scholar 

  10. Ottesen LH, Flyvbjerg A, Jakobsen P, Bendtsen F (1997) The pharmacokinetics of octreotide in cirrhosis and in healthy man. J Hepatol 26:1018–1025

    Article  PubMed  CAS  Google Scholar 

  11. Satta A, Faedda R, Chiandussi L, Bartoli E (1983) Fluid and electrolytes in liver disease. Postgrad Med J 59(Suppl 4):64–72

    PubMed  CAS  Google Scholar 

  12. Romano G, Favret G, Federico E, Bartoli E (1998) The site of action of furosemide. Pharmacol Res 37:409–419

    Article  PubMed  CAS  Google Scholar 

  13. Lubetsky A, Winaver J, Seligmann H, Olchovsky D, Almog S, Halkin H, Ezra D (1999) Urinary thiamine excretion in the rat: effects of furosemide, other diuretics, and volume load. J Lab Clin Med 134:232–237

    Article  PubMed  CAS  Google Scholar 

  14. Gentilini P, Romanelli RG, Laffi G, Barletta G, Del Bene R, Messeri G, La Villa G (1999) Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. J Hepatol 30:632–638

    Article  PubMed  CAS  Google Scholar 

  15. Schwartz JB (2003) Gender-specific implications for cardiovascular medication use in the elderly optimizing therapy for older women. Cardiol Rev 11:275–298

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mario Pirisi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toniutto, P., Pirisi, M., Fabris, C. et al. The Significance of the Furosemide Test for Predicting Ascites Control by Diuretics in Cirrhotics: A Comparison with Volume Expansion and Octreotide Infusion. Dig Dis Sci 51, 1992–1997 (2006). https://doi.org/10.1007/s10620-005-9072-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-9072-2

Keywords

Navigation